zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler for systemisk bruk, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
orfiril 300 mg
desitin arzneimittel gmbh - natriumvalproat - enterotablett - 300 mg
orfiril long 500 mg
desitin arzneimittel gmbh - natriumvalproat - depotgranulat - 500 mg
orfiril long 1000 mg
desitin arzneimittel gmbh - natriumvalproat - depotgranulat - 1000 mg
orfiril long 150 mg
desitin arzneimittel gmbh - natriumvalproat - depotkapsel, hard - 150 mg
orfiril long 300 mg
desitin arzneimittel gmbh - natriumvalproat - depotkapsel, hard - 300 mg
orfiril 150 mg
desitin arzneimittel gmbh - natriumvalproat - enterotablett - 150 mg
orfiril 600 mg
desitin arzneimittel gmbh - natriumvalproat - enterotablett - 600 mg
orfiril 100 mg/ ml
desitin arzneimittel gmbh - natriumvalproat - injeksjonsvæske, oppløsning - 100 mg/ ml
orfiril 60 mg/ ml
desitin arzneimittel gmbh - natriumvalproat - mikstur, oppløsning - 60 mg/ ml